Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,908,571 papers from all fields of science
Search
Sign In
Create Free Account
Forced Expiratory Flow at 25-75 Percent
Known as:
FEF2575
, Forced Expiratory Flow 25-75%
The mean forced expiratory flow rate at 25-75% of the forced vital capacity.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
CDISC SDTM Respiratory Test Name Terminology
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis
I. Vizel’
,
A. Vizel’
2015
Corpus ID: 79341550
Objective: Methotrexate (MTX) is a cytotoxic agent that is commonly employed as an alternative to corticosteroids to treat…
Expand
2013
2013
A Comparative Study of Pulmonary Function Tests in Children and Adolescents, in a Rural Area of Guntur District, Andhra Pradesh, India
V. Venu
,
G. Raju
,
K. M. Babu
,
G. Chaitanya
2013
Corpus ID: 73713238
Introduction : Pulmonary Function Tests are used to measure baseline status of respiratory function, to monitor treatment and to…
Expand
2013
2013
Study of Diurnal Variation of Pulmonary Function Test
B. Prasad
,
B. Ashika
2013
Corpus ID: 71459718
Pulmonary function has circadian rhythm in humans proven in diseased in conditions. These variations will contribute to better…
Expand
2012
2012
Obesity and Spirometric Ventilatory Status Correlation in Adult Male Population of Amritsar
S. Mahajan
,
A. Arora
,
P. Gupta
2012
Corpus ID: 55294652
Aims & Objective: To study the effects of obesity on the lung functions in adult male population of Amritsar Materials and…
Expand
2009
2009
Lung clearance of 99mTc-DTPA in ankylosing spondylitis.
M. Çabuk
,
S. Ozdolap
,
+6 authors
K. Mahmutyazicioglu
Hellenic journal of nuclear medicine
2009
Corpus ID: 46178853
The association of ankylosing spondylitis (AS) and lung parenchyma abnormalities has been shown in previous studies by…
Expand
2007
2007
Spirometric reference values for children and adolescents from Kazakhstan
F. Facchini
,
G. Fiori
,
+8 authors
M. Goldoni
Annals of Human Biology
2007
Corpus ID: 6025054
Background: Spirometric parameters are influenced by several factors and many reference data are available in the literature…
Expand
1998
1998
[Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].
J. Derelle
,
E. Bertolo-Houriez
,
F. Marchal
,
M. Weber
,
J. Virion
,
M. Vidailhet
Archives de pédiatrie
1998
Corpus ID: 13173377
AIM Modifications of bronchial secretions in cystic fibrosis patients account for the long-lasting use of mucolytic agents…
Expand
1996
1996
Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
A. Grove
,
B. Lipworth
Thorax
1996
Corpus ID: 10927980
BACKGROUND: Previous studies have shown that both salmeterol and formoterol act as partial beta 2 receptor agonists in terms of…
Expand
Highly Cited
1990
Highly Cited
1990
Effects of passive smoking on the pulmonary function of adults.
M. Masjedi
,
Homayoun Kazemi
,
Douglas C. Johnson
Thorax
1990
Corpus ID: 1106026
The effects of exposure to environmental tobacco smoke (passive smoking) on pulmonary function of non-smoking, healthy Iranian…
Expand
Review
1990
Review
1990
[Repercussion of risk factors associated with the development of chronic bronchial pathology on pulmonary function in children].
J. Sanz Ortega
,
A. Martorell Aragonés
,
+7 authors
A. Díaz Martínez
Anales espanoles de pediatria
1990
Corpus ID: 41393364
Of a total of 1,566 children, 1,416 of both sexes and aged 7 to 14 were subjected to functional respiratory exploration with a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE